(Q51095285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

main subject

phase II clinical trial

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

David C. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

B G Redman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

L E Flaherty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

L Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

M Strawderman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

257-260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Effects of high-dose ketoconazole in patients with androgen-independent prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Haemostatic changes during hormone manipulation in advanced prostate cancer: a comparison of DES 3 mg/day and goserelin 3.6 mg/month

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urolo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Hormonal Therapy of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Comparison of Megace, Stilphostrol, Megace plus DES, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Combined hormonal therapy with high-dose diethylstilbestrol diphosphate (DES-DP) intravenous infusion plus vindesine (VND) for the treatment of advanced prostatic carcinoma: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

High-dose intravenous estrogen therapy in advanced prostatic carcinoma. Use of serum prostate-specific antigen to monitor response.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Clinical trial of massive stilboestrol diphosphate therapy in advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

THE PLACE OF HONVAN (DIETHYLSTILBOESTROL DIPHOSPHATE) IN THE TREATMENT OF PROSTATIC CANCER; A REVIEW OF TWENTY-FOUR CASES

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900173-3

7 January 2021

10.1016/S0090-4295(98)00173-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9697791%20AND%20SRC:MED&resulttype=core&format=json

release_avq3iir3cncdhcypwlraecycau

2 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/avq3iir3cncdhcypwlraecycau

24 November 2022

mapped directly with Wikidata item

1 reference